<!DOCTYPE frameset SYSTEM "frameset.dtd">
<frameset>
   <predicate lemma="deglycosylate">
      <roleset framenet="" id="deglycosylate.01" name="remove the sugar entity from a glycogen (but especially from a glycoprotein)">
         <aliases>
            <alias framenet="" pos="v" verbnet="">deglycosylate</alias>
            <alias framenet="" pos="n" verbnet="">deglycosylation</alias>
         </aliases>
         <roles>
            <role descr="intentional agent of deglycosylation (e.g. scientist)" f="" n="0" />
            <role descr="thing deglycosylated (e.g. protein)" f="" n="1" />
            <role descr="instrument" f="" n="2" />
            <role descr="result of deglycosylation" f="" n="3" />
            <note>For Bio-AMR annotations.</note>
         </roles>
         <example name="example with intentional agent" src="" type="">
            <text>Therefore, we deglycosylated human recombinant dimeric eA5 and tested on GBM cells.</text>
            <arg f="" n="0">we</arg>
            <arg f="" n="1">human recombinant dimeric eA5</arg>
         </example>
         <example name="example with instrument" src="" type="">
            <text>In initial studies, bovine or human TSH preparations were deglycosylated with anhydrous hydrogen fluoride or trifluoromethanesulfonic acid (137-139).</text>
            <arg f="" n="1">bovine or human TSH preparations</arg>
            <arg f="" n="2">anhydrous hydrogen fluoride or trifluoromethanesulfonic acid</arg>
         </example>
         <example name="example with result" src="" type="">
            <text>Receptors were solubilized, immunoprecipitated, and deglycosylated from 2 mg of membrane protein, and blotted with each of these antibodies.</text>
            <arg f="" n="1">2 mg of membrane protein</arg>
            <arg f="" n="3">Receptors</arg>
         </example>
      </roleset>
   </predicate>
</frameset>